Advertisement
Research ArticleORIGINAL ARTICLE

A Synthetic Derivative of the Natural Product Rocaglaol Is a Potent Inhibitor of Cytokine-Mediated Signaling and Shows Neuroprotective Activity in Vitro and in Animal Models of Parkinson's Disease and Traumatic Brain Injury

T. Fahrig, I. Gerlach and E. Horváth
Molecular Pharmacology May 2005, 67 (5) 1544-1555; DOI: https://doi.org/10.1124/mol.104.008177
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleORIGINAL ARTICLE

A Synthetic Derivative of the Natural Product Rocaglaol Is a Potent Inhibitor of Cytokine-Mediated Signaling and Shows Neuroprotective Activity in Vitro and in Animal Models of Parkinson's Disease and Traumatic Brain Injury

T. Fahrig, I. Gerlach and E. Horváth
Molecular Pharmacology May 1, 2005, 67 (5) 1544-1555; DOI: https://doi.org/10.1124/mol.104.008177
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement